• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病(IBD)的生物标志物诊断和预测与结肠炎相关的癌症。

MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer.

机构信息

Department of Pathology, Herlev University Hospital, 2730 Herlev, Denmark.

The Pediatric Department, Copenhagen University Hospital, 2650 Hvidovre, Denmark.

出版信息

Int J Mol Sci. 2020 Oct 24;21(21):7893. doi: 10.3390/ijms21217893.

DOI:10.3390/ijms21217893
PMID:33114313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7660644/
Abstract

Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC). These are chronic autoimmune diseases of unknown etiology affecting the gastrointestinal tract. The IBD population includes a heterogeneous group of patients with varying disease courses requiring personalized treatment protocols. The complexity of the disease often delays the diagnosis and the initiation of appropriate treatments. In a subset of patients, IBD leads to colitis-associated cancer (CAC). MicroRNAs are single-stranded regulatory noncoding RNAs of 18 to 22 nucleotides with putative roles in the pathogenesis of IBD and colorectal cancer. They have been explored as biomarkers and therapeutic targets. Both tissue-derived and circulating microRNAs have emerged as promising biomarkers in the differential diagnosis and in the prognosis of disease severity of IBD as well as predictive biomarkers in drug resistance. In addition, knowledge of the cellular localization of differentially expressed microRNAs is a prerequisite for deciphering the biological role of these important epigenetic regulators and the cellular localization may even contribute to an alternative repertoire of biomarkers. In this review, we discuss findings based on RT-qPCR, microarray profiling, next generation sequencing and in situ hybridization of microRNA biomarkers identified in the circulation and in tissue biopsies.

摘要

炎症性肠病(IBD)包括克罗恩病(CD)和溃疡性结肠炎(UC)。这些是病因不明的慢性自身免疫性疾病,影响胃肠道。IBD 患者群体包括具有不同疾病过程的异质患者群体,需要个性化的治疗方案。疾病的复杂性常常导致诊断和适当治疗的延迟。在一部分患者中,IBD 会导致结肠炎相关癌症(CAC)。microRNAs 是具有 18 至 22 个核苷酸的单链调节性非编码 RNA,在 IBD 和结直肠癌的发病机制中具有潜在作用。它们已被探索作为生物标志物和治疗靶点。组织来源和循环 microRNAs 已作为有前途的生物标志物,用于 IBD 的鉴别诊断和疾病严重程度的预后,以及耐药性的预测生物标志物。此外,对差异表达 microRNAs 的细胞定位的了解是破译这些重要表观遗传调节剂的生物学作用的前提,细胞定位甚至可能有助于替代生物标志物的组合。在这篇综述中,我们讨论了基于 RT-qPCR、微阵列分析、下一代测序和组织活检中循环和组织中 microRNA 生物标志物的原位杂交的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5356/7660644/f6b61f5afd69/ijms-21-07893-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5356/7660644/f6b61f5afd69/ijms-21-07893-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5356/7660644/f6b61f5afd69/ijms-21-07893-g001.jpg

相似文献

1
MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer.炎症性肠病(IBD)的生物标志物诊断和预测与结肠炎相关的癌症。
Int J Mol Sci. 2020 Oct 24;21(21):7893. doi: 10.3390/ijms21217893.
2
MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.微小RNA特征可区分克罗恩病与溃疡性结肠炎。
BMC Immunol. 2015 Feb 10;16:5. doi: 10.1186/s12865-015-0069-0.
3
MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer.微小 RNA 作为炎症性肠病的创新生物标志物及结直肠癌预测指标。
Int J Mol Sci. 2022 Jul 20;23(14):7991. doi: 10.3390/ijms23147991.
4
MicroRNA in inflammatory bowel disease: Translational research and clinical implication.炎症性肠病中的微小RNA:转化研究与临床意义
World J Gastroenterol. 2015 Nov 21;21(43):12274-82. doi: 10.3748/wjg.v21.i43.12274.
5
The landscape of miRNA-mRNA regulatory network and cellular sources in inflammatory bowel diseases: insights from text mining and single cell RNA sequencing analysis.miRNA-mRNA 调控网络和细胞来源在炎症性肠病中的研究现状:文本挖掘和单细胞 RNA 测序分析的启示。
Front Immunol. 2024 Aug 22;15:1454532. doi: 10.3389/fimmu.2024.1454532. eCollection 2024.
6
MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.微小 RNA 表达对溃疡性结肠炎和克罗恩病的影响:用于鉴定诊断生物标志物的初步研究。
World J Gastroenterol. 2021 Dec 7;27(45):7801-7812. doi: 10.3748/wjg.v27.i45.7801.
7
Role of MiRNAs in Inflammatory Bowel Disease.微小RNA在炎症性肠病中的作用
Dig Dis Sci. 2017 Jun;62(6):1426-1438. doi: 10.1007/s10620-017-4567-1. Epub 2017 Apr 8.
8
Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease.炎症性肠病患儿黏膜微小RNA表达的改变
Dig Liver Dis. 2017 Apr;49(4):378-387. doi: 10.1016/j.dld.2016.12.022. Epub 2016 Dec 27.
9
Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease.microRNAs 在炎症性肠病中的功能作用和治疗靶点。
Am J Physiol Gastrointest Liver Physiol. 2018 Feb 1;314(2):G256-G262. doi: 10.1152/ajpgi.00268.2017. Epub 2017 Nov 16.
10
MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?炎症性肠病中的 microRNAs:我们知道什么,我们可以期待什么?
World J Gastroenterol. 2024 Apr 28;30(16):2184-2190. doi: 10.3748/wjg.v30.i16.2184.

引用本文的文献

1
MicroRNAs in the Diagnosis of Digestive Diseases: A Comprehensive Review.微小RNA在消化系统疾病诊断中的应用:综述
J Clin Med. 2025 Mar 18;14(6):2054. doi: 10.3390/jcm14062054.
2
Genetic factors that predict response and failure of biologic therapy in inflammatory bowel disease.预测炎症性肠病生物治疗反应和失败的遗传因素。
World J Exp Med. 2025 Mar 20;15(1):97404. doi: 10.5493/wjem.v15.i1.97404.
3
The role of miRNAs in the pathogenesis, diagnosis, and treatment of colorectal cancer and colitis-associated cancer.微小RNA在结直肠癌及结肠炎相关癌的发病机制、诊断和治疗中的作用。

本文引用的文献

1
MiR-155 contributes to intestinal barrier dysfunction in DSS-induced mice colitis via targeting HIF-1α/TFF-3 axis.miR-155 通过靶向 HIF-1α/TFF-3 轴促进 DSS 诱导的小鼠结肠炎肠屏障功能障碍。
Aging (Albany NY). 2020 Jul 26;12(14):14966-14977. doi: 10.18632/aging.103555.
2
microRNA in inflammatory bowel disease at a glance.炎症性肠病中的 microRNA 一览。
Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):140-148. doi: 10.1097/MEG.0000000000001815.
3
Is tofacitinib a game-changing drug for ulcerative colitis?托法替布是否为溃疡性结肠炎带来变革性药物?
Clin Exp Med. 2025 Mar 16;25(1):86. doi: 10.1007/s10238-025-01582-6.
4
MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel disease.微小 RNA 特征在炎症性肠病发病机制和治疗中的作用。
Clin Exp Med. 2024 Sep 11;24(1):217. doi: 10.1007/s10238-024-01476-z.
5
The Contribution of Genetic and Epigenetic Factors: An Emerging Concept in the Assessment and Prognosis of Inflammatory Bowel Diseases.遗传和表观遗传因素的贡献:炎症性肠病评估和预后的新兴概念。
Int J Mol Sci. 2024 Aug 1;25(15):8420. doi: 10.3390/ijms25158420.
6
Diagnostic Procedures for Inflammatory Bowel Disease: Laboratory, Endoscopy, Pathology, Imaging, and Beyond.炎症性肠病的诊断程序:实验室检查、内镜检查、病理学检查、影像学检查及其他
Diagnostics (Basel). 2024 Jun 28;14(13):1384. doi: 10.3390/diagnostics14131384.
7
The Diagnosis of Intestinal Fibrosis in Crohn's Disease-Present and Future.克罗恩病肠纤维化的诊断——现状与未来。
Int J Mol Sci. 2024 Jun 25;25(13):6935. doi: 10.3390/ijms25136935.
8
miR-155 and miR-21 as Diagnostic and Therapeutic Biomarkers for Ulcerative Colitis: There Is Still a Long Way to Go.微小RNA-155和微小RNA-21作为溃疡性结肠炎的诊断和治疗生物标志物:仍有很长的路要走。
Biomedicines. 2024 Jun 13;12(6):1315. doi: 10.3390/biomedicines12061315.
9
Dynamic changes in extracellular vesicle-associated miRNAs elicited by ultrasound in inflammatory bowel disease patients.超声刺激诱导炎症性肠病患者细胞外囊泡相关 miRNA 的动态变化。
Sci Rep. 2024 May 13;14(1):10925. doi: 10.1038/s41598-024-61532-2.
10
MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?炎症性肠病中的 microRNAs:我们知道什么,我们可以期待什么?
World J Gastroenterol. 2024 Apr 28;30(16):2184-2190. doi: 10.3748/wjg.v30.i16.2184.
United European Gastroenterol J. 2020 Aug;8(7):755-763. doi: 10.1177/2050640620935732. Epub 2020 Jun 18.
4
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics.miR-21作为癌症生物标志物的潜在作用及其在基于RNA的治疗中的重要性。
Mol Ther Nucleic Acids. 2020 Jun 5;20:409-420. doi: 10.1016/j.omtn.2020.03.003. Epub 2020 Mar 13.
5
Cruel to Be Kind: Epithelial, Microbial, and Immune Cell Interactions in Gastrointestinal Cancers.残忍即仁慈:胃肠道癌症中的上皮细胞、微生物和免疫细胞相互作用。
Annu Rev Immunol. 2020 Apr 26;38:649-671. doi: 10.1146/annurev-immunol-082019-081656. Epub 2020 Feb 10.
6
The role of the miR-21-5p-mediated inflammatory pathway in ulcerative colitis.miR-21-5p介导的炎症通路在溃疡性结肠炎中的作用。
Exp Ther Med. 2020 Feb;19(2):981-989. doi: 10.3892/etm.2019.8277. Epub 2019 Dec 4.
7
Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass.用于盆腔肿块患者卵巢癌的诊断性血浆 miRNA 图谱。
PLoS One. 2019 Nov 18;14(11):e0225249. doi: 10.1371/journal.pone.0225249. eCollection 2019.
8
MicroRNAs, intestinal inflammatory and tumor.微小 RNA,肠道炎症与肿瘤。
Bioorg Med Chem Lett. 2019 Aug 15;29(16):2051-2058. doi: 10.1016/j.bmcl.2019.06.013. Epub 2019 Jun 12.
9
The Fire within: Cell-Autonomous Mechanisms in Inflammation-Driven Cancer.《火中取栗:炎症驱动癌症中的细胞自主机制》
Cancer Cell. 2019 May 13;35(5):714-720. doi: 10.1016/j.ccell.2019.04.001.
10
The incidence of cancer and mortality in paediatric onset inflammatory bowel disease in Denmark and Finland during a 23-year period: a population-based study.丹麦和芬兰 23 年间儿科发病炎症性肠病的癌症发病率和死亡率:一项基于人群的研究。
Aliment Pharmacol Ther. 2019 Jul;50(1):33-39. doi: 10.1111/apt.15258. Epub 2019 May 8.